MedTrace Logo

Bioavailability Study of Clonazepam ODT Under Fasting Conditions

NCT00652912 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2008-04-04

No results posted yet for this study

Summary

To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT

Conditions

  • To Determine Bioequivalence Under Fasting Conditions

Interventions

DRUG

Clonazepam

ODT, 1 mg

DRUG

Klonopin Wafers

ODT, 1 mg

Sponsors & Collaborators

  • Cetero Research, San Antonio

    collaborator NETWORK

  • Par Pharmaceutical, Inc.

    lead INDUSTRY

Principal Investigators

  • Ali Ziaee · Cetero Research, San Antonio

  • Gary Shillito · Cetero Research, San Antonio

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2004-04-30
Completion
2004-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00652912 on ClinicalTrials.gov